Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendeles

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Calcium antagonists in the management of asthma: breakthrough or ballyhoo?K L Massey, L Hendeles
Chest|August 24, 1999
Low- vs high-dose inhaled albuterol for the treatment of acute asthmaM J Asmus, L Hendeles
Journal of the American Dental Association (1939)|July 1, 1983
Tetracycline and lactationL Hendeles, P A Trask
American Journal of Hospital Pharmacy|June 1, 1974
Guide to total dose intravenous iron dextran therapyD B Hanson, L Hendeles
The Annals of Pharmacotherapy|July 1, 1996
Zileuton: a new therapy for asthma or just the first of a new class of drugsL Hendeles, P L Marshik
Pharmacotherapy|March 11, 2000
Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?M J Asmus, L Hendeles
Pharmacotherapy|November 1, 1993
Reassessing the therapeutic range for theophylline: another perspectiveM M Weinberger, L Hendeles
The Annals of Pharmacotherapy|September 20, 1997
Zafirlukast for chronic asthma: convenient and generally safe, but is it effective?L Hendeles, P L Marshik
American Journal of Hospital Pharmacy|September 1, 1974
Letter: Potential carcinogenicity of iron dextranL Hendeles, D B Hanson
Clinical Pharmacokinetics|July 1, 1978
Monitoring serum theophylline levelsL Hendeles, M Weinberger, G Johnson
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Calcium antagonists in the management of asthma: breakthrough or ballyhoo?K L Massey, L Hendeles
Chest|August 24, 1999
Low- vs high-dose inhaled albuterol for the treatment of acute asthmaM J Asmus, L Hendeles
Journal of the American Dental Association (1939)|July 1, 1983
Tetracycline and lactationL Hendeles, P A Trask
American Journal of Hospital Pharmacy|June 1, 1974
Guide to total dose intravenous iron dextran therapyD B Hanson, L Hendeles
The Annals of Pharmacotherapy|July 1, 1996
Zileuton: a new therapy for asthma or just the first of a new class of drugsL Hendeles, P L Marshik
Pharmacotherapy|March 11, 2000
Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?M J Asmus, L Hendeles
Pharmacotherapy|November 1, 1993
Reassessing the therapeutic range for theophylline: another perspectiveM M Weinberger, L Hendeles
The Annals of Pharmacotherapy|September 20, 1997
Zafirlukast for chronic asthma: convenient and generally safe, but is it effective?L Hendeles, P L Marshik
American Journal of Hospital Pharmacy|September 1, 1974
Letter: Potential carcinogenicity of iron dextranL Hendeles, D B Hanson
Clinical Pharmacokinetics|July 1, 1978
Monitoring serum theophylline levelsL Hendeles, M Weinberger, G Johnson
Pageof 16